Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.655 USD | -2.62% | +6.15% | +78.54% |
07/05 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
01/05 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+78.54% | 3.36B | |
+3.84% | 108B | |
+11.20% | 104B | |
+1.28% | 22.33B | |
-13.09% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.06% | 17.64B | |
+3.68% | 14.05B | |
+36.73% | 12.51B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Summit Therapeutics Names Manmeet Soni as Chief Operating Officer